ConductScience.org, home

Paper40862425

Hepatoprotective effect of lotus leaf against non-alcoholic fatty liver disease in rats via alteration of AMPK/SIRT1 and Nrf2/HO-1 signaling pathway.

Shen Q and 5 others. Acta Cir Bras, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Hepatoprotective effect of lotus leaf against non-alcoholic fatty liver disease in rats via alteration of AMPK/SIRT1 and Nrf2/HO-1 signaling pathway. Papers, record 40862425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40862425

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hepatoprotective effect of lotus leaf against non-alcoholic fatty liver disease in rats via alteration of AMPK/SIRT1 and Nrf2/HO-1 signaling pathway.
PubMed
Journal
Acta Cir Bras
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-09-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Non-alcoholic Fatty Liver DiseaseMajor topic
Sirtuin 1Major topic
NF-E2-Related Factor 2Major topic
Plant LeavesMajor topic
Plant ExtractsMajor topic
Animals
Signal Transduction
Male
AMP-Activated Protein Kinases
Oxidative Stress
Diet, High-Fat
Liver
Rats, Wistar
Rats
Cytokines
Heme Oxygenase (Decyclizing)
Protective Agents
Disease Models, Animal
Heme Oxygenase-1

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136203933The AMPK pathway in fatty liver disease.Front Physiol2022https://conductscience.org/library/papers/36203933PubMed
225372397Antioxidant and anticancer aporphine alkaloids from the leaves of Nelumbo nucifera Gaertn. cv. Rosa-plena.Molecules2014https://conductscience.org/library/papers/25372397PubMed
329633106Probiotic mixture of Lactobacillus and Bifidobacterium alleviates systemic adiposity and inflammation in non-alcoholic fatty liver disease rats through Gpr109a and the commensal metabolite butyrate.Inflammopharmacology2018https://conductscience.org/library/papers/29633106PubMed
434371577Phytochemical Screening, Antioxidant and Sperm Viability of Nelumbo nucifera Petal Extracts.Plants (Basel)2021https://conductscience.org/library/papers/34371577PubMed
524489777Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.PLoS One2014https://conductscience.org/library/papers/24489777PubMed
635689859Extract of Jasminum grandiflorum L. alleviates CCl4-induced liver injury by decreasing inflammation, oxidative stress and hepatic CYP2E1 expression in mice.Biomed Pharmacother2022https://conductscience.org/library/papers/35689859PubMed
733662429SET8 mitigates hepatic ischemia/reperfusion injury in mice by suppressing MARK4/NLRP3 inflammasome pathway.Life Sci2021https://conductscience.org/library/papers/33662429PubMed
837979064Obesity and Dyslipidemia.Curr Atheroscler Rep2023https://conductscience.org/library/papers/37979064PubMed
924454330Dyslipidemia in rat fed with high-fat diet is not associated with PCSK9-LDL-receptor pathway but ageing.J Geriatr Cardiol2013https://conductscience.org/library/papers/24454330PubMed
1039243432Berberine alleviates fructose-induced hepatic injury via ADK/AMPK/Nrf2 pathway: A novel insight.Biomed Pharmacother2024https://conductscience.org/library/papers/39243432PubMed
1138203796The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review.Int J Mol Sci2024https://conductscience.org/library/papers/38203796PubMed
1233425700Anti-aging potential and phytochemicals of Centella asiatica, Nelumbo nucifera, and Hibiscus sabdariffa extracts.J Adv Pharm Technol Res2020https://conductscience.org/library/papers/33425700PubMed
1338647851Lotus (Nelumbo nucifera): a multidisciplinary review of its cultural, ecological, and nutraceutical significance.Bioresour Bioprocess2024https://conductscience.org/library/papers/38647851PubMed
1438036934Regulation and targeting of SREBP-1 in hepatocellular carcinoma.Cancer Metastasis Rev2024https://conductscience.org/library/papers/38036934PubMed
1538076077Exfoliation and physico-chemical characterization of novel bioplasticizers from Nelumbo nucifera leaf for biofilm application.Heliyon2023https://conductscience.org/library/papers/38076077PubMed
1635757691The Role of NLRP3 Inflammasome Activation Pathway of Hepatic Macrophages in Liver Ischemia-Reperfusion Injury.Front Immunol2022https://conductscience.org/library/papers/35757691PubMed
1720041406Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.Hepatology2010https://conductscience.org/library/papers/20041406PubMed
1831165007The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases.Aging Dis2019https://conductscience.org/library/papers/31165007PubMed
1935542112Deconvoluting the dual hypoglycemic effect of wedelolactone isolated from Wedelia calendulacea: investigation via experimental validation and molecular docking.RSC Adv2018https://conductscience.org/library/papers/35542112PubMed
2032149275Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism.JHEP Rep2019https://conductscience.org/library/papers/32149275PubMed

See all 39 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42939910Phenolic Profiles and Antioxidant Potential of Nymphaea and Nelumbo Species: Botanical Authentication, Redox-Modulating Mechanisms, and Translational Perspectives.Antioxidants (Basel)2026https://conductscience.org/library/papers/42939910PubMed
42051254Preclinical evaluation of puerarin for the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis.Front Pharmacol2026https://conductscience.org/library/papers/42051254PubMed
41614829Chemical Composition and Bioactivity of Nelumbo nucifera Gaertn. Flower Extract Fractions: In Vitro Antioxidant and Anti-Inflammatory Properties.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41614829PubMed
41222323Green-Synthesized Silver Nanoparticles from Garlic Peel Target NF-κB and Redox Imbalance: A Novel Therapeutic Strategy Against Pyrogallol-Induced Hepatotoxicity in Rats.Nanomaterials (Basel)2025https://conductscience.org/library/papers/41222323PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40862425

GET https://conductscience.org/api/papers/v1/40862425/references?page=2